Aurobindo Pharma: Aurobindo Unit Gets Usfda Nod For Ryzeneuta | Hyderabad News

Hyderabad: Pharma major Aurobindo Pharma on Wednesday said the US Food & Drug Administration (USFDA) has approved Ryzneuta (Efbemalenograstim alfa inj.

Related Keywords

Bombay ,Maharashtra ,India ,Hyderabad ,Andhra Pradesh ,Barabanki ,Uttar Pradesh ,Yifan ,Zhejiang ,China ,Chinese ,Ramkuber Singh ,Ashish Anvekar ,Ryzneuta Efbemalenograstim ,Aurobindo Pharma ,Acrotech Biopharma ,Yifan Pharmaceutical Co Ltd ,Bombay Stock Exchange ,Us Food Drug Administration ,China National Medical Products Administration ,Drug Administration ,Induced Neutropenia ,Hyderabad Based Aurobindo ,National Medical Products Administration ,Evive Biotech ,Hyderabad News ,Yderabad Latest News ,Yderabad News Live ,Yderabad News Today ,Oday News Hyderabad ,Usfda ,Ryzneuta ,Granulocyte Colony Stimulating Factor ,Efbemalenograstim Alfa Injection ,